NO20013507D0 - Sammensetning til å behandle inflammatorisk respons - Google Patents

Sammensetning til å behandle inflammatorisk respons

Info

Publication number
NO20013507D0
NO20013507D0 NO20013507A NO20013507A NO20013507D0 NO 20013507 D0 NO20013507 D0 NO 20013507D0 NO 20013507 A NO20013507 A NO 20013507A NO 20013507 A NO20013507 A NO 20013507A NO 20013507 D0 NO20013507 D0 NO 20013507D0
Authority
NO
Norway
Prior art keywords
composition
inflammatory response
treating inflammatory
treating
response
Prior art date
Application number
NO20013507A
Other languages
English (en)
Other versions
NO321216B1 (no
NO20013507L (no
Inventor
Joel M Linden
Gail W Sullivan
Ian J Sarembock
Timothy Macdonald
Mark Okusa
Irving L Kron
Michael W Scheld
Original Assignee
Univ Virginia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/333,387 external-priority patent/US6232297B1/en
Application filed by Univ Virginia filed Critical Univ Virginia
Publication of NO20013507D0 publication Critical patent/NO20013507D0/no
Publication of NO20013507L publication Critical patent/NO20013507L/no
Publication of NO321216B1 publication Critical patent/NO321216B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/167—Purine radicals with ribosyl as the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20013507A 1999-02-01 2001-07-13 Blandinger for behandling av inflammatoriske reaksjoner NO321216B1 (no)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US11802999P 1999-02-01 1999-02-01
US12431699P 1999-03-12 1999-03-12
US13337499P 1999-05-10 1999-05-10
US13557399P 1999-05-24 1999-05-24
US09/333,387 US6232297B1 (en) 1999-02-01 1999-06-15 Methods and compositions for treating inflammatory response
US15141299P 1999-08-30 1999-08-30
PCT/US2000/002324 WO2000044763A2 (en) 1999-02-01 2000-01-31 Compositions for treating inflammatory response

Publications (3)

Publication Number Publication Date
NO20013507D0 true NO20013507D0 (no) 2001-07-13
NO20013507L NO20013507L (no) 2001-09-18
NO321216B1 NO321216B1 (no) 2006-04-03

Family

ID=27557920

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013507A NO321216B1 (no) 1999-02-01 2001-07-13 Blandinger for behandling av inflammatoriske reaksjoner

Country Status (26)

Country Link
EP (1) EP1150991B1 (no)
JP (1) JP4837831B2 (no)
KR (1) KR100668006B1 (no)
CN (1) CN1191266C (no)
AR (1) AR029332A1 (no)
AT (1) ATE263777T1 (no)
AU (2) AU778870B2 (no)
BR (1) BR0007864A (no)
CA (1) CA2361614C (no)
CZ (1) CZ296404B6 (no)
DE (1) DE60009665T2 (no)
DK (1) DK1150991T3 (no)
EE (1) EE05185B1 (no)
ES (1) ES2215609T3 (no)
HK (1) HK1047288A1 (no)
HU (1) HU228937B1 (no)
IL (2) IL144188A0 (no)
MX (1) MXPA01007850A (no)
MY (1) MY129445A (no)
NO (1) NO321216B1 (no)
NZ (1) NZ513096A (no)
PL (1) PL199953B1 (no)
PT (1) PT1150991E (no)
SK (1) SK284877B6 (no)
UA (1) UA72912C2 (no)
WO (1) WO2000044763A2 (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6448235B1 (en) 1994-07-11 2002-09-10 University Of Virginia Patent Foundation Method for treating restenosis with A2A adenosine receptor agonists
US6514949B1 (en) 1994-07-11 2003-02-04 University Of Virginia Patent Foundation Method compositions for treating the inflammatory response
US6232297B1 (en) 1999-02-01 2001-05-15 University Of Virginia Patent Foundation Methods and compositions for treating inflammatory response
US7378400B2 (en) 1999-02-01 2008-05-27 University Of Virginia Patent Foundation Method to reduce an inflammatory response from arthritis
US7427606B2 (en) 1999-02-01 2008-09-23 University Of Virginia Patent Foundation Method to reduce inflammatory response in transplanted tissue
US6322771B1 (en) * 1999-06-18 2001-11-27 University Of Virginia Patent Foundation Induction of pharmacological stress with adenosine receptor agonists
IL133680A0 (en) * 1999-09-10 2001-04-30 Can Fite Technologies Ltd Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
WO2003029264A2 (en) 2001-10-01 2003-04-10 University Of Virginia Patent Foundation 2-propynyl adenosine analogs having a2a agonist activity and compositions thereof
US20050033044A1 (en) 2003-05-19 2005-02-10 Bristol-Myers Squibb Pharma Company Methods for preparing 2-alkynyladenosine derivatives
EP1740587A4 (en) * 2004-04-02 2009-07-15 Adenosine Therapeutics Llc SELECTIVE ANTAGONISTS OF A2A ADENOSINE RECEPTORS
US7396825B2 (en) * 2004-05-03 2008-07-08 University Of Virginia Patent Foundation Agonists of A2A adenosine receptors for treatment of diabetic nephropathy
WO2006023272A1 (en) 2004-08-02 2006-03-02 University Of Virginia Patent Foundation 2-polycyclic propynyl adenosine analogs having a2a agonist activity
WO2006028618A1 (en) 2004-08-02 2006-03-16 University Of Virginia Patent Foundation 2-polycyclic propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity
EP1778712B1 (en) * 2004-08-02 2013-01-30 University Of Virginia Patent Foundation 2-propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity
US8178509B2 (en) 2006-02-10 2012-05-15 University Of Virginia Patent Foundation Method to treat sickle cell disease
US20100048501A1 (en) 2006-03-21 2010-02-25 Heinrich-Heine-Universitat Dusseldorf Phosphorylated A2A Receptor Agonists
US8188063B2 (en) 2006-06-19 2012-05-29 University Of Virginia Patent Foundation Use of adenosine A2A modulators to treat spinal cord injury
US8058259B2 (en) 2007-12-20 2011-11-15 University Of Virginia Patent Foundation Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
US20100003193A1 (en) 2008-07-03 2010-01-07 University Of Virginia Patent Foundation Unit dosage of apadenoson
US8263762B2 (en) 2009-06-30 2012-09-11 Dogwood Pharmaceuticals, Inc. Alkoxy-carbonyl-amino-alkynyl-adenosine compounds and derivatives thereof as A2AR agonists
FR2960876B1 (fr) 2010-06-03 2012-07-27 Sanofi Aventis Derives de 3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide leur preparation et leur application en therapeutique.
JP2022538410A (ja) * 2019-06-21 2022-09-02 アカデミー オブ ミリタリー メディカル サイエンシズ Ａ２ａアデノシン受容体拮抗作用を有する小分子化合物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3537228A1 (de) * 1985-10-19 1987-04-23 Huels Chemische Werke Ag Verfahren zur herstellung von cyclohexylverbindungen
JPS6299330A (ja) * 1985-10-25 1987-05-08 Yamasa Shoyu Co Ltd 抗高血圧剤
US5270304A (en) * 1988-11-15 1993-12-14 Yamasa Shoyu Kabushiki Kaisha Therapeutic 2-alkynyl adenosine agent for ischemic diseases of the heart or brain
ES2077070T3 (es) * 1989-06-20 1995-11-16 Yamasa Shoyu Kk Intermedio de sintesis de 2-alquiniladenosina, produccion de dicho intermedio, produccion de 2-alquiniladenosina a partir de dicho intermedio, y derivado de 2-alquiniladenosina estable.
WO1991009864A1 (en) * 1990-01-04 1991-07-11 Yamasa Shoyu Kabushiki Kaisha Drug for treating or preventing ischemic diseases of heart or brain
JPH03287537A (ja) * 1990-03-31 1991-12-18 Yamasa Shoyu Co Ltd 抗動脈硬化症剤
JP3025559B2 (ja) * 1990-07-19 2000-03-27 ヤマサ醤油株式会社 アデノシン誘導体
JP3053908B2 (ja) * 1991-06-28 2000-06-19 ヤマサ醤油株式会社 ２‐アルキニルアデノシン誘導体
JP3025557B2 (ja) * 1991-06-28 2000-03-27 ヤマサ醤油株式会社 ２‐アルキニルアデノシン誘導体
IT1254915B (it) * 1992-04-24 1995-10-11 Gloria Cristalli Derivati di adenosina ad attivita' a2 agonista
AU7449598A (en) * 1997-05-23 1998-12-11 Nippon Shinyaku Co. Ltd. Medicinal composition for prevention or treatment of hepatopathy
EP1014995A4 (en) * 1997-06-18 2005-02-16 Aderis Pharmaceuticals Inc COMPOSITIONS AND METHODS FOR PREVENTING RESTENOSES CONSECUTIVE TO REVASCULARIZATION INTERVENTIONS
JPH11335302A (ja) * 1998-05-26 1999-12-07 Toa Eiyo Ltd 安定な医薬組成物
JP3619017B2 (ja) * 1998-06-24 2005-02-09 日本臓器製薬株式会社 新規アラビノシルアデニン誘導体
JP2002173427A (ja) * 1998-09-01 2002-06-21 Yamasa Shoyu Co Ltd 眼疾患治療用医薬組成物

Also Published As

Publication number Publication date
PT1150991E (pt) 2004-08-31
CZ296404B6 (cs) 2006-03-15
BR0007864A (pt) 2001-11-06
CA2361614C (en) 2008-08-26
DK1150991T3 (da) 2004-06-07
CA2361614A1 (en) 2000-08-03
ES2215609T3 (es) 2004-10-16
NO321216B1 (no) 2006-04-03
ATE263777T1 (de) 2004-04-15
HK1047288A1 (en) 2003-02-14
AU2745400A (en) 2000-08-18
MY129445A (en) 2007-04-30
CN1357002A (zh) 2002-07-03
CZ20012781A3 (cs) 2002-01-16
JP2002536300A (ja) 2002-10-29
UA72912C2 (uk) 2005-05-16
MXPA01007850A (es) 2002-08-20
KR100668006B1 (ko) 2007-01-15
WO2000044763A2 (en) 2000-08-03
AR029332A1 (es) 2003-06-25
DE60009665D1 (de) 2004-05-13
SK10972001A3 (sk) 2002-01-07
CA2361614E (en) 2000-08-03
IL144188A0 (en) 2002-05-23
HU228937B1 (en) 2013-06-28
EE05185B1 (et) 2009-06-15
WO2000044763A3 (en) 2000-12-14
NO20013507L (no) 2001-09-18
JP4837831B2 (ja) 2011-12-14
NZ513096A (en) 2003-01-31
KR20020013494A (ko) 2002-02-20
AU2005201255A1 (en) 2005-04-21
IL144188A (en) 2008-12-29
EE200100397A (et) 2002-08-15
PL199953B1 (pl) 2008-11-28
DE60009665T2 (de) 2004-08-19
SK284877B6 (sk) 2006-01-05
AU2005201255B2 (en) 2008-02-28
HUP0200224A3 (en) 2005-02-28
CN1191266C (zh) 2005-03-02
AU778870B2 (en) 2004-12-23
EP1150991A2 (en) 2001-11-07
HUP0200224A2 (en) 2002-06-29
EP1150991B1 (en) 2004-04-07

Similar Documents

Publication Publication Date Title
NO20013507D0 (no) Sammensetning til å behandle inflammatorisk respons
NO20014607D0 (no) Sammensetninger til forbedring av fertilitet
DE60013221D1 (de) Fotopolymerisierbare Zusammensetzung
IS6120A (is) Lyfjablanda
ATE316978T1 (de) Ent-steroide als selektiv wirksame estrogene
EE200100420A (et) Kütusekoostis
DE60000776D1 (de) Reinigungsmittelzusammensetzung
DE60019927D1 (de) Modifizierte alkylarylsulfonat-tenside enthaltende reinigungsmittelzusammensetzungen
AR023440A1 (es) Composiciones antitranspirantes
DE69922267D1 (de) Bewegliches zusammensetzspiel
ATE232364T1 (de) Zuckergusszusammensetzung
NO20011602D0 (no) Midler for forbedring av utskillelsespotensialet til urinblæren
ID29785A (id) Komposisi-komposisi sampo
ATE257691T1 (de) Schweisshemmende zusammensetzungen
DE69908845D1 (de) Fotoresistzusammensetzung
DE60016948D1 (de) Waschmittelzusammensetzung
DE69943245D1 (de) Gaserzeugende zusammensetzung
DE60016836D1 (de) Resistzusammensetzung
ATE313553T1 (de) 16-hydroxyestratriene als selektiv wirksame estrogene
DE60022111D1 (de) Waschmittelzusammensetzung
DE60020341D1 (de) Kerzenzusammensetzung
PT1158963E (pt) Composicoes de libertacao controlada de beta-histina
FR2791258B1 (fr) Composition amincissante
BR0016210B1 (pt) Composição detergente em barra
DE60020682D1 (de) Resorcinenthaltende zusammensetzung

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees